Glycoengineering Chinese hamster ovary cells: A short history

23Citations
Citations of this article
75Readers
Mendeley users who have this article in their library.

Abstract

Biotherapeutic glycoproteins have revolutionised the field of pharmaceuticals, with new discoveries and continuous improvements underpinning the rapid growth of this industry. N-glycosylation is a critical quality attribute of biotherapeutic glycoproteins that influences the efficacy, half-life and immunogenicity of these drugs. This review will focus on the advances and future directions of remodelling N-glycosylation in Chinese hamster ovary (CHO) cells, which are the workhorse of recombinant biotherapeutic production, with particular emphasis on antibody products, using strategies such as cell line and protein backbone engineering.

Cite

CITATION STYLE

APA

Donini, R., Haslam, S. M., & Kontoravdi, C. (2021, April 1). Glycoengineering Chinese hamster ovary cells: A short history. Biochemical Society Transactions. Portland Press Ltd. https://doi.org/10.1042/BST20200840

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free